Vanguard Personalized Indexing Management’s Lyell Immunopharma LYEL Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio LYEL Stock Details LYEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-1,644	Closed	-$17.7K	–	1998
2025 Q1	$17.7K	Buy	1,644 +525	+47%	+$6.43K	﹤0.01%	1786
2024 Q4	$14.3K	Buy	+1,119	New	+$22.2K	﹤0.01%	1787
2024 Q3	–	Sell	-934	Closed	-$27.1K	–	1802
2024 Q2	$27.1K	Buy	934 +115	+14%	+$5.47K	﹤0.01%	1628
2024 Q1	$36.5K	Buy	819 +23	+3%	+$985	﹤0.01%	1581
2023 Q4	$30.9K	Buy	+796	New	+$28.7K	﹤0.01%	1533

Other funds holding LYEL

Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return

MWG Management Road Town, Tortola, British Virgin Islands $81.3M AUM 2.28% 1-Year Est. Return

Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return

Orland Properties Ltd Road Town, Tortola, British Virgin Islands $267M AUM 5.05% 1-Year Est. Return

Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return

Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return

venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Foresite Capital Management V Larkspur, California $271M AUM 309.87% 1-Year Est. Return

T. Rowe Price Associates

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return